All In Biotech

Free tool

FAERS Monitor: Dotarem

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204781 or its brand name (Dotarem, Gadoterate Meglumine). Reports on generic versions are filed under their own applications.

Reports

3,261

Serious

2,312

71% of reports

Hospitalization

798

Death reported

64

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • urticaria612
  • dyspnoea488
  • nausea476
  • pruritus453
  • vomiting384
  • erythema376
  • cough270
  • rash253
  • product use in unapproved indication205
  • dizziness187
  • headache184
  • paraesthesia159
  • throat irritation155
  • sneezing118
  • chest discomfort117

Reports by year received

View as table
YearReports
20042
20051
20061
20072
20082
20092
20105
20115
20127
201367
201466
2015221
2016225
2017258
2018395
2019313
2020333
2021264
2022220
2023237
2024239
2025194
2026202

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,898 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sneezingSignal11834.128.63,743
urticariaSignal61223.622.013,307
throat irritationSignal15522.419.23,137
erythemaSignal37611.810.73,742
pruritusSignal4537.67.02,640
chest discomfortSignal1177.46.2641
paraesthesiaSignal1596.55.6743
coughSignal2706.25.51,191
dyspnoeaSignal4885.65.11,871
product use in unapproved indicationSignal2055.34.7726
vomitingSignal3845.34.81,354
nauseaSignal4763.93.61,054
rashSignal2533.73.3517
dizzinessSignal1872.42.1158
headache1841.91.679

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.